Rebalix
Logo iSharesiShares · sheet of 10 September 2026
ETF sheet · official issuer and register data

iShares US Medical Devices UCITS ETF

UMDV · IE00BMX0DF60 · USD · domicile Ireland
Equity · United States · Health care · Large & mid capSFDR art. 6
Index tracked: Dow Jones U.S. Select Medical Equipment Capped 35/20 NET Index (USD)
TER
0.25%+ trans. 0.00%
Fund size
207 m EUR
Tracking difference
−0.04%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 3 Aug 2020 · costs from the KID as of 2 Sept 2026 · 46 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the Dow Jones U.S. Select Medical Equipment Capped 35/20 Index, the Fund’s benchmark index (Index). The Share Class, via the Fund is passively managed, and aims to invest in equity securities (e.g. shares) that, so far as possible and practicable, make up the Index and comply with the index provider’s liquidity eligibility criteria, size and free float criteria.…

Performance since series start (in euro) — base 100

3 Aug 202031 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
20212022202320242025202615797117
High 157 (10 Feb 2025) · low 97 (24 Sept 2020) · last 117. Past performance is not indicative of future results.

Returns in euro

1 year−13.0%
3 years−1.0%
5 years−11.2%
10 yearsseries too young
Since series start+17.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)20.57%18.10%19.50%
Max drawdown−27.39%−27.80%−31.49%
Sharpe-1.00-0.05-0.26
Sortino-1.37-0.06-0.36
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · UMDV · IE00BMX0DF601
RebalixUMDV · IE00BMX0DF60 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+6.95%+7.01%−0.06%
2024+10.73%+10.78%−0.05%
2023+4.46%+4.48%−0.02%
2022−19.73%−19.66%−0.07%
2021+21.29%+21.44%−0.16%

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 46 securities · top-10 weight = 81.9%
Top holdingsWeight
ABBOTT LABORATORIES18.7%
INTUITIVE SURGICAL13.0%
MEDTRONIC PLC11.3%
STRYKER10.9%
BOSTON SCIENTIFIC CORP7.0%
EDWARDS LIFESCIENCES5.1%
BECTON DICKINSON5.0%
IDEXX LABORATORIES4.3%
DEXCOM INC3.4%
RESMED3.4%
Countries (% of fund)
United States99.9%Ireland0.1%
Sectors (% of fund)
Health Care99.9%Cash and/or Derivatives0.1%

Listing venues

ESMA register (FIRDS) and official exchange lists
U5MD · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 19 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.ishares.com/gls-download/literature/fact-sheet/umdv-ishares-us-med
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE00BMX0DF60
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · UMDV · IE00BMX0DF602